Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Patient Satisfaction × Imiquimod × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Keratosis, Actinic 24 Uterine Cervical Dysplasia 11 Carcinoma, Basal Cell 10 Melanoma 7 Glioblastoma 6 Glioma 5 Breast Neoplasms 5 Uterine Cervical Neoplasms 4 Condylomata Acuminata 4 Precancerous Conditions 3 Papillomavirus Infections 3 Hutchinson's Melanotic Freckle 3 Vulvar Neoplasms 2 Urinary Bladder Neoplasms 2 Squamous Intraepithelial Lesions 2 Non-Muscle Invasive Bladder Neoplasms 2 Neoplasms 2 Neoplasm Metastasis 2 Keratosis 2 Hemangioma, Capillary 2 HIV Infections 2 Ependymoma 2 Colorectal Neoplasms 2 Brain Neoplasms 2 Astrocytoma 2 Warts 1 Vulvar High Grade Squamous Intraepithelial Lesion (HSIL) 1 Virus Diseases 1 Vaginal Neoplasms 1 Stomach Neoplasms 1

Interventions

Propofol 2 Vascular Access Devices 1 Uterine Artery Embolization 1 Tranexamic Acid 1 Surgical Procedures, Operative 1 Patient Transfer 1 Parapsychology 1 Music Therapy 1 Midazolam 1 Lidocaine 1 Imiquimod 1 Ibuprofen 1 Fentanyl 1 Exercise 1 Drainage 1 Control Groups 1 Colonoscopy 1 Bandages, Hydrocolloid 1 Ambulatory Care 1 Alfentanil 1 Aftercare 1 Acetaminophen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01861535 2021-04-14

PITVIN

Medical University of Graz

Phase 3 Completed

Patient Satisfaction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡